Log in
Enquire now
Triveni Bio

Triveni Bio

Triveni Bio focuses on the identification of novel disease by combining human genetics and precision medicine.

OverviewStructured DataIssuesContributors

Contents

triveni.bio
Is a
Organization
Organization
Company
Company

Company attributes

Industry
Manufacturing
Manufacturing
Health technology
Health technology
Pharmaceutical industry
Pharmaceutical industry
Location
Waltham, Massachusetts
Waltham, Massachusetts
B2X
B2B2C
B2B2C
CEO
‌
Vishal Patel
Number of Employees (Ranges)
11 – 50
Email Address
Investors
Deep Track Capital
Deep Track Capital
OrbiMed
OrbiMed
Invus
Invus
Cormorant Asset Management
Cormorant Asset Management
Goldman Sachs Asset Management
Goldman Sachs Asset Management
Fidelity Investments
Fidelity Investments
Viking Global Investors
Viking Global Investors
Total Funding Amount (USD)
115,000,000
Latest Funding Round Date
October 2, 2024
Latest Funding Type
Series B
Series B

Other attributes

Latest Funding Round Amount (USD)
115,000,000
No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like Triveni Bio

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Pricing
  • Enterprise

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.